⚡ Nicotine Pouches

About

Nicotine pouches are small, white sachets placed under the lip to deliver nicotine without tobacco leaf, smoke, or vapor. Unlike snus, they contain no tobacco — only pharmaceutical-grade nicotine, plant fibers, and flavorings. Brands like ZYN (Philip Morris International) and on! (Altria) have driven explosive mainstream adoption since 2019, particularly among adult smokers seeking smokeless alternatives.

Market

Global nicotine pouch revenues surpassed $4 billion in 2024 and are growing at over 35% annually — the fastest growth rate of any nicotine product category. The US is the dominant market, with ZYN alone shipping over 800 million cans in 2024. Scandinavia (where the category originated) and the UK are established markets; Eastern Europe and Southeast Asia are emerging. The category is now the primary growth driver for major tobacco companies transitioning away from combustibles.

Regulation

Regulatory status varies sharply by jurisdiction. The US FDA authorized ZYN as a Modified Risk Tobacco Product (MRTP) in 2024 — a significant regulatory endorsement. The EU bans nicotine pouches in most member states under tobacco product regulations, though enforcement is inconsistent and reform discussions are ongoing. Australia prohibits them without a prescription. Many countries apply no specific rules, defaulting to general consumer product law. The overall trajectory is toward explicit regulation (either permissive or restrictive) as the category becomes too large to ignore.